Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Gefitinib-induced paronychia teated by cyosurgery
- Authors
- Kim, S[Kim, Song]; Park, JH[Park, Ji-Ho]; Kim, WS[Kim, Won-Serk]; Lee, JH[Lee, Joo-Heung]; Yang, JM[Yang, Jun-Mo]; Lee, ES[Lee, Eil-Soo]
- Issue Date
- Dec-2007
- Publisher
- KOREAN DERMATOLOGICAL ASSOC
- Keywords
- cryosurgery; gefitinib; paronychia
- Citation
- ANNALS OF DERMATOLOGY, v.19, no.4, pp.173 - 175
- Indexed
- SCIE
KCI
OTHER
- Journal Title
- ANNALS OF DERMATOLOGY
- Volume
- 19
- Number
- 4
- Start Page
- 173
- End Page
- 175
- ISSN
- 1013-9087
- Abstract
- Gefitinib (Iressa, ZD1839) is one of the epidermal growth factor receptor (EGFR) inhibitors approved for the treatment of advanced non-small cell lung cancer. The cutaneous reactions to EGFR inhibitors manifest as a follicular eruption, nail toxicity, xerosis, or desquamation. These adverse events, if not properly managed, can interfere with activities of daily living. We report a case of paronychia induced by gefitinib successfully treated with cryosurgery which is a simple and safe treatment.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.